Author

Yong Li

St. Jude Children's Research HospitalORCID 0000-0001-9629-1137Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Yong Li7 papers · BGI Group (China)

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Bioinformatics· 1 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:deep learning· 2 Research Focus:drug response / drug discovery· 2 Approach:statistical model· 2 Research Focus:benchmarking· 1 Research Focus:database / resource· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:metabolomics· 1

Frequent Co-Authors

Lei YangiD· 3 shared Abhilash JayarajiD· 1 shared Abhishek Kumar· 1 shared Aditya KumariD· 1 shared AkshatKumar NigamiD· 1 shared Alán Aspuru‐GuzikiD· 1 shared Alexander HassoniD· 1 shared Amr AlhossaryiD· 1 shared

Activity by Year

2023-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 30 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersBiochemistry

Lei YangORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

BiochemistryAnalytical ChemistryPeer-reviewedSep 12, 2025

rtmsEcho: An Open-Source R Package for Automated Analysis of Acoustic Ejection Mass Spectrometry Data

Mary Ashley Rimmer, Nathaniel R. Twarog, Tharindu A. Ranathunge…·Lei Yang

rtmsEcho automates AEMS data processing tasks like peak detection and multimodal analysis, improving efficiency in high-throughput applications.

2 citations

metabolomicsdeep learning

𝕏 PostBluesky

Cancer BiologybioRxivPreprintJul 3, 2025

LCK-targeting molecular glues overcome resistance to inhibitor-based therapy in T-cell acute lymphoblastic leukemia

Jun J Yang, Gisele Nishiguchi, Satoshi Yoshimura…·Marcus M. Fischer

This study develops LCK-targeting molecular glues that overcome resistance to kinase inhibitors in T-ALL by inducing CRBN-dependent degradation of LCK.

1 citation

humanproteomics

𝕏 PostBluesky

BioinformaticsbioRxivPreprintApr 25, 2023

AI-Enhanced Adaptive Virtual Screening Platform Enabling Exploration of 69 Billion Molecules Discovers Structurally Validated FSP1 Inhibitors

Domiziana Cecchini, AkshatKumar Nigam, Ming Tang…·Christoph Gorgulla

AdaptiveFlow enables large-scale virtual screening of 69 billion molecules to discover validated FSP1 inhibitors, improving efficiency and scalability in drug discovery.

24 citations

experimental assaydrug response / drug discovery

𝕏 PostBluesky